Exchange: NASDAQ·Updated 04:00 PM EDT

BHST News

News
all
press releases
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -30.77% and -10.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
Celldex (CLDX) delivered earnings and revenue surprises of +9.62% and -98.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of +26.53% and +186.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Phathom Pharmaceuticals, Inc. (PHAT) Reports Break-Even Earnings for Q2
Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of +100.00% and +1.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
BioHarvest Sciences Q1 Earnings Call Highlights
BioHarvest Sciences Q1 Earnings Call Highlights...
Yahoo! Finance: News
BioHarvest Sciences Q1 revenue climbs as it expands botanical synthesis pipeline
BioHarvest Sciences Q1 revenue climbs as it expands botanical synthesis pipeline...
Yahoo! Finance: News
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +15.39% and +0.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Bionano Genomics (BNGO) delivered earnings and revenue surprises of +6.17% and +2.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Will BioHarvest Sciences Inc. (BHST) Report Negative Earnings Next Week? What You Should Know
BioHarvest Sciences Inc. (BHST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.